CLSN Celsion
Celsion is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative cancer treatments, including immunotherapies and DNA-based therapies; and a platform for the development of nucleic acid vaccines currently focused on SARS-CoV2. The company's product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer. ThermoDox®, a proprietary heat-activated liposomal encapsulation of doxorubicin, is under investigator-sponsored development for several cancer indications. Celsion also has two feasibility stage platform technologies for the development of novel nucleic acid-based immunotherapies and other anti-cancer DNA or RNA therapies. Both are novel synthetic, non-viral vectors with demonstrated capability in nucleic acid cellular transfection.
Company profile
Ticker
CLSN
Exchange
Website
CEO
Michael Tardugno
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
CHEUNG LABORATORIES INC
SEC CIK
Corporate docs
IRS number
521256615
CLSN stock data
()
News
Celsion Highlights Results From OVATION 1 Study With GEN-1 In Patients With Advanced Ovarian Cancer Published In Journal Of Clinical Cancer Research
29 Jul 21
31 Stocks Moving in Thursday's Pre-Market Session
8 Jul 21
Celsion Reports Commencement Of Enrollment In Oxford University's Phase 1 Study With Its ThermoDox, Focused Ultrasound In Pancreatic Cancer
1 Jul 21
Celsion Says Establishes Wholly Owned Subsidiary To Manage Investigator-Sponsored Development Of ThermoDox
23 Jun 21
Celsion Corporation Enters into $10M Strategic Loan Facility with Silicon Valley Bank
21 Jun 21
Press releases
Results of Celsion's OVATION 1 Study with GEN-1 in Patients with Advanced Ovarian Cancer Published in the Journal of Clinical Cancer Research
29 Jul 21
Celsion Appoints Christine A. Pellizzari to its Board of Directors
9 Jun 21
Celsion Corporation Appoints Dr. Stacy R. Lindborg to its Board of Directors
8 Jun 21
CELSION CORPORATION ANNOUNCES ADJOURNMENT OF ANNUAL MEETING
7 Jun 21
CELSION CORPORATION ANNOUNCES ADJOURNMENT OF ANNUAL MEETING
4 Jun 21
Investment data
Securities sold
Number of investors
Calendar
14 May 21
29 Jul 21
31 Dec 21
Financial summary
Quarter (USD) |
Mar 21 | Dec 20 | Sep 20 | Jun 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
Annual (USD) |
Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
Financial data from Celsion earnings reports.
| Cash burn rate (estimated) | Burn method: Change in cash | Burn method: Operating income/loss | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 37.76M | 37.76M | 37.76M | 37.76M | 37.76M | 37.76M |
| Cash burn (monthly) | (positive/no burn) | (positive/no burn) | 1.79M | 1.59M | 1.58M | 1.28M |
| Cash used (since last report) | n/a | n/a | 7.1M | 6.3M | 6.25M | 5.07M |
| Cash remaining | n/a | n/a | 30.66M | 31.46M | 31.51M | 32.69M |
| Runway (months of cash) | n/a | n/a | 17.1 | 19.8 | 20.0 | 25.5 |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 8 Jun 21 | Christine A Pellizzari | Option to Purchase Celsion Corporation Common Stock Celsion Corporation Common Stock | Grant | Aquire A | No | No | 1.25 | 40,000 | 50K | 40,000 |
| 4 Jun 21 | Stacy Lindborg | Option to Purchase Celsion Corporation Common Stock Celsion Corporation Common Stock | Grant | Aquire A | No | No | 1.24 | 40,000 | 49.6K | 40,000 |
| 17 May 21 | Braun Donald P | Celsion Corporation Common Stock | Buy | Aquire P | No | No | 1.07 | 5,000 | 5.35K | 5,357 |
Institutional ownership Q1 2021
Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.
13F holders |
Current |
|---|---|
| Total holders | 0 |
| Opened positions | 0 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
13F shares |
Current |
|---|---|
| Total value | 0 |
| Total shares | 0 |
| Total puts | 0 |
| Total calls | 0 |
| Total put/call ratio | – |
Largest owners |
Shares | Value |
|---|
Financial report summary
?Competition
Codiak BiosciencesManagement Discussion
- For the three months ended March 31, 2021, our net loss was $5.7 million compared to a net loss of $5.1 million for the same three-month period of 2020.
- With $54.6 million in cash and cash equivalents, short-term investments, and receivable on sale of net operating losses at March 31, 2021, coupled with approximately $15 million of gross proceeds received from the sale of equity in the March 2021 Offering closed on April 5, 2021 and with future sales of the Company’s State of New Jersey net operating losses, the Company believes it has sufficient capital resources to fund its operations through 2024.
Content analysis
?
| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. junior Avg
|
|
New words:
abdomen, AGP, amenable, antibody, antigen, Arcadia, assembly, augmenting, Avastin, bench, bilayer, biocompatibility, Biodistribution, bioterrorism, bladder, bloodstream, body, boost, branched, Brookline, built, burn, carrier, cationic, Cautionary, central, cGMP, chemotherapeutic, cholesterol, compatible, composed, concept, confluence, conjugation, contest, Cox, CRADA, CRO, cyclophosphamide, deadliest, deployment, destroy, dictating, die, differentiated, differentiation, disperse, distant, dramatically, Dutch, easily, eleven, entitle, entry, epidemiologic, escape, escaping, evolutionary, exacerbate, Fidler, flexible, forecast, forensic, forty, frozen, functional, functionalization, furnish, GLOBALCAN, glycol, gynecological, heavy, helper, hepatic, HIFU, humoral, immunogenic, immunogenicity, Importantly, incorrect, induction, ineffective, ineligible, inserted, intradermally, intramuscularly, intratumoral, Japan, justify, killer, led, Legislature, lent, lethal, lifetime, London, longstanding, Magnetic, manuscript, mBC, membrane, metastatic, Michael, microwave, mitomycin, monovalent, Mortality, mouse, multifunctional, multitude, multivalent, mutation, mutational, naked, neutralizing, nucleocapsid, opposed, opsonization, outer, Oxford, pain, pancreatic, PanDox, paper, parallel, pathogen, peer, PEG, Pegylated, PEI, percent, periphery, PLACCINE, platinum, polyethylene, polyethyleneimine, polymeric, PPC, probe, proliferation, propensity, prophylactic, protonation, provisional, quantify, radiation, redoubling, Regression, reproducible, residence, resistance, resistant, Resonance, rollout, sequence, shorter, simplifying, simultaneously, Society, speak, stability, subcutaneously, submicroscopic, surface, swelling, Tardugno, team, temperature, threshold, tightly, topotecan, transplantation, ultrasound, unavailability, unusual, upcoming, uptake, Utrecht, vaccine, viral, virally, virtual, vivo, zone
Removed:
abandon, abroad, abundance, abuse, abusive, ACA, accept, accident, Accountability, accuracy, accurate, accurately, achievement, acquire, acquiring, adapted, adequately, adhere, advantage, affecting, afflicted, agree, alleging, alleviate, allotted, alter, alternate, Alternatively, ameliorated, amend, America, American, analyst, analyzing, anticipate, applied, appointing, approve, Area, argued, Aspire, assert, asserting, assimilating, assuming, assure, attempting, attention, attributed, authorization, authorize, authorized, authorizing, automatic, avoiding, aware, back, Bank, base, BBA, behalf, belief, beneficial, bidder, bill, billion, biologic, biological, biosimilar, Bipartisan, blank, Blueprint, bode, branded, breached, Brexit, bribe, bring, broader, broadly, budget, budgeted, bulk, burden, burdensome, California, call, cap, CBER, cease, certification, certify, certiorari, challenged, charter, check, CIO, Circuit, circumvent, civil, claim, claimed, closure, Code, Codification, codified, collaboration, collected, collection, commencement, commercially, commit, communicable, comparatively, comparator, compare, competent, competing, competition, complicating, complied, comply, complying, compromised, computer, concealing, conclusion, concurrently, conferring, confidence, confidential, confidentiality, confirm, confirming, congressional, constantly, constitute, constrain, constraining, consultation, consumer, consuming, contingent, continuity, contracted, contractual, Conversely, corridor, costly, country, cover, covering, covertly, created, creation, credible, criminal, critical, curtailment, custody, customer, cutoff, daily, damaged, damaging, dated, deal, dealing, decide, declare, decreasing, deductibility, deemed, defective, defended, defending, defer, deficient, defraud, delayed, delaying, demonstrate, denial, denied, depart, departure, deposited, designate, desire, detectable, deterioration, determination, developmental, deviate, device, devoted, diagnose, difficult, diligence, dilute, dilution, diminished, disaster, disclaim, disclose, discontinuation, discounting, discourage, discovered, disproportionate, dispute, disputed, disrupted, distancing, distribute, diversification, diversify, diversion, divert, diverting, domestic, donut, drop, DSMB, earthquake, East, economy, EEA, electrical, eligibility, enable, enabling, enacted, enactment, encompassed, encounter, encountered, encourage, enforce, enforceable, enforced, enforcement, enhancing, ensure, ensuring, entail, entirety, escalating, establishing, estimation, evolve, evolving, exact, exclusion, exclusive, executing, execution, exemption, exhaustive, existence, exit, expedited, expend, expenditure, expensive, experimental, expert, exploiting, explosion, exposed, extend, extensively, external, extreme, facilitating, facing, factual, failure, faith, fall, falsifying, faster, favorably, FCA, federal, feedback, field, fill, fire, flat, flood, fluctuate, force, forced, forcing, forfeiture, formal, formulary, Framework, fraudulent, freely, fundamental, furlough, gain, gaining, gap, gave, GDPR, GEN, generallybut, generic, genetic, geographic, governing, grow, guide, guilty, halted, hand, harm, harmed, heard, hereof, hesitancy, HHS, HIPAA, hire, historically, history, HITECH, hold, hole, hospital, hour, House, Hubei, identifiable, identifying, IL, ill, imaging, impair, impending, implanted, implement, implementation, implemented, implementing, import, importation, impose, imposed, imposing, imposition, impossible, imprisonment, improperly, inappropriate, incentivize, incident, inconclusive, incorporation, increasingly, incurrence, IND, indefinitely, indemnify, independently, individually, induce, influence, informed, infrastructure, infringe, infringed, infringement, infringing, infused, inhaled, inherently, initiate, initiation, injury, input, inspection, instilled, instituted, institution, insufficient, integrate, integration, intense, intent, intention, interference, interpretation, interpreted, interpreting, interrupt, interrupted, interruption, introduction, invasive, invention, inventor, investigated, investigating, investigation, investor, involving, judge, judicial, kickback, kind, Kingdom, knew, knowingly, label, labeling, landscape, largest, launched, leave, legally, legislation, legislative, lengthen, liable, licensed, lieu, liquidated, liquidating, list, listing, location, long, lose, losing, lost, lower, lowering, maintaining, man, manage, managed, managerial, mandate, mandated, manmade, manufacturer, matrix, meaningful, Medicaid, medically, Medicare, medication, member, merger, merging, messenger, methodology, minimizing, mitigation, modify, moiety, monetary, movement, multinational, narrow, necessity, negatively, negotiate, negotiated, negotiating, North, novelty, nurse, objectionable, obsolete, obtained, obtaining, occurrence, operational, opposition, opt, opted, oral, outage, outlining, outpatient, overcoming, oversight, overtly, owed, packaging, paragraph, partially, party, passed, passing, patented, Paycheck, payer, paying, payor, payroll, penalty, pending, perception, perform, performed, permanently, permissible, permitted, person, perspective, phantom, pharmacoeconomic, physician, planning, play, pocket, policy, Political, pool, Portability, pose, possessing, post, postpone, power, PPP, precedent, precise, predicted, preempted, preferentially, prescription, presenting, President, prevalence, prevented, privacy, proceed, proceeding, processing, profitably, promise, promotional, promulgate, prosecution, prospect, protecting, Province, proximity, publicity, publicly, pursuing, put, qualified, qualify, quantity, qui, RAC, rare, reach, readout, realize, rebate, recall, receipt, recommending, record, recording, recordkeeping, recover, recovered, recruit, recruitment, referral, registering, regular, regulate, reimbursed, relate, released, relevant, reliance, reliant, Relief, relieve, reluctance, rely, remanded, remuneration, render, repeal, repealed, replace, replaced, replicated, represent, representation, representative, reputation, reputational, request, requiring, researched, resolve, restraining, restructuring, retain, retained, retroactive, returned, revalidation, revise, revocation, revoke, reward, risky, routine, royalty, ruled, ruling, running, satisfaction, satisfactorily, satisfactory, satisfied, SBA, scheme, scrutiny, secret, secure, Securing, seizure, Select, Senate, setting, shipping, short, shortage, side, Silicon, similarly, situation, slower, social, solicited, soliciting, source, specialty, spending, sponsoring, staffing, statute, statutory, step, stimulate, strain, strict, stricter, strictly, structuring, studied, subjecting, submission, submit, substance, succeeded, suffer, suggest, Sunshine, supervise, supplant, supplement, supplied, supplying, supranational, Supreme, surveillance, susceptible, suspend, suspended, suspension, sustain, tam, tariff, tasked, taxable, taxation, Taxpayer, teaching, technological, telecommunication, temporarily, terrorism, test, tested, timeline, toll, tradable, trade, Trademark, trading, train, transferring, transmission, transmit, transparency, transport, treble, trend, TRICARE, trick, trillion, Trump, turn, turnover, type, ultimate, unable, unacceptable, unanticipated, unauthorized, uncertain, unconstitutional, understand, underway, undesirable, unenforceable, unexpectedly, unfair, unfavorable, unforeseen, uniform, unintentionally, unknown, unpatented, unplanned, unpredictable, unprofitable, unreasonable, unrelated, unsuccessful, upheld, urge, user, utilization, valid, validation, Valley, valuable, variance, varying, viability, view, violate, violating, violation, volatile, voluntary, vulnerable, waive, war, warning, weather, whistleblower, wide, willfully, withdraw, withdrawal, withhold, worsen, Wuhan
Financial reports
10-Q
2021 Q1
Quarterly report
14 May 21
10-K
2020 FY
Annual report
19 Mar 21
10-Q
2020 Q3
Quarterly report
16 Nov 20
10-Q
2020 Q2
Quarterly report
14 Aug 20
10-Q
2020 Q1
Quarterly report
15 May 20
10-K
2019 FY
Annual report
25 Mar 20
10-Q
2019 Q3
Quarterly report
14 Nov 19
10-Q
2019 Q2
Quarterly report
13 Aug 19
10-Q
2019 Q1
Quarterly report
15 May 19
10-K
2018 FY
Annual report
29 Mar 19
Current reports
8-K
Celsion Corporation Enters into $10 Million Strategic Loan Facility with Silicon Valley Bank
21 Jun 21
8-K
Celsion Corporation Appoints Dr. Stacy R. Lindborg to its Board of Directors
10 Jun 21
8-K
Celsion Corporation Announces Adjournment of Annual Meeting
7 Jun 21
8-K
Celsion Corporation Announces Adjournment of Annual Meeting
4 Jun 21
8-K
Celsion Corporation Reports First Quarter 2021 Financial Results and Provides Business Update
14 May 21
8-K
Celsion Corporation Announces $15 Million Registered Direct Offering
2 Apr 21
8-K
Celsion Corporation Reports 2020 Financial Results and Provides Business Update
19 Mar 21
8-K
Celsion Corporation Issues Letter to Stockholders
11 Feb 21
8-K
Other Events
3 Feb 21
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
29 Jan 21
Registration and prospectus
424B5
Prospectus supplement for primary offering
2 Apr 21
S-3
Shelf registration
19 Mar 21
424B5
Prospectus supplement for primary offering
25 Jan 21
424B5
Prospectus supplement for primary offering
25 Jan 21
S-3
Shelf registration
9 Oct 20
424B5
Prospectus supplement for primary offering
8 Sep 20
S-3/A
Shelf registration (amended)
11 Aug 20
S-8
Registration of securities for employees
31 Jul 20
S-3
Shelf registration
31 Jul 20
424B5
Prospectus supplement for primary offering
22 Jun 20
Proxies
DEFA14A
Additional proxy soliciting materials
7 Jun 21
DEFA14A
Additional proxy soliciting materials
4 Jun 21
DEFA14A
Additional proxy soliciting materials
27 May 21
DEF 14A
Definitive proxy
20 Apr 21
PRER14A
Preliminary revised proxy
12 Apr 21
PRE 14A
Preliminary proxy
8 Apr 21
DEF 14A
Definitive proxy
29 Apr 20
DEF 14A
Definitive proxy
29 Mar 19
DEF 14A
Definitive proxy
29 Mar 18
DEF 14A
Definitive proxy
3 Apr 17
Other
EFFECT
Notice of effectiveness
31 Mar 21
CORRESP
Correspondence with SEC
25 Mar 21
UPLOAD
Letter from SEC
23 Mar 21
EFFECT
Notice of effectiveness
28 Oct 20
CORRESP
Correspondence with SEC
22 Oct 20
UPLOAD
Letter from SEC
15 Oct 20
EFFECT
Notice of effectiveness
14 Aug 20
CORRESP
Correspondence with SEC
10 Aug 20
UPLOAD
Letter from SEC
6 Aug 20
EFFECT
Notice of effectiveness
29 Nov 19
Ownership
4
Celsion / Christine A Pellizzari ownership change
9 Jun 21
3
Celsion / Christine A Pellizzari ownership change
9 Jun 21
4
Celsion / Stacy Lindborg ownership change
8 Jun 21
3
Celsion / Stacy Lindborg ownership change
8 Jun 21
4
Celsion / Donald P Braun ownership change
20 May 21
4
Celsion / Timothy J Tumminello ownership change
22 Mar 21
4
Celsion / JEFFREY WAYNE CHURCH ownership change
22 Mar 21
4
Celsion / Michael H Tardugno ownership change
22 Mar 21
4
Celsion / Andreas Voss ownership change
22 Mar 21
4
Celsion / Donald P Braun ownership change
22 Mar 21
Transcripts
2021 Q1
Earnings call transcript
14 May 21
2020 Q4
Earnings call transcript
19 Mar 21
2020 Q3
Earnings call transcript
16 Nov 20
2020 Q2
Earnings call transcript
14 Aug 20
2020 Q1
Earnings call transcript
15 May 20
2019 Q4
Earnings call transcript
26 Mar 20
2019 Q3
Earnings call transcript
15 Nov 19
2019 Q2
Earnings call transcript
15 Aug 19
2019 Q1
Earnings call transcript
15 May 19
2018 Q4
Earnings call transcript
29 Mar 19
Reddit threads
THE LOUNGE/DAILY PLAYS July 29, 2021
28 Jul 21
THE LOUNGE/DAILY PLAYS July 26, 2021
25 Jul 21
THE LOUNGE/DAILY PLAYS July 21, 2021
20 Jul 21
THE LOUNGE/DAILY PLAYS July 20, 2021
19 Jul 21
THE LOUNGE/DAILY PLAYS July 19, 2021
18 Jul 21
Citius Pharmaceuticals, Inc. Announces Positive Recommendation by Independent Data Monitoring Committee to Continue the Mino-Lok® Phase 3 Trial as Planned
1 Jul 21
Four Stock Ideas That I think is going to explode in the June of 2021 that are also Swing-Tradable $PEI $VBIV $CLSN $BOXL
5 Jun 21
Worst buys you’ve made this year so far
18 May 21
Daily Discussion Thread - May 14th, 2021
14 May 21
Daily Discussion Thread - May 13th, 2021
13 May 21